![Zohar Koren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zohar Koren
Chief Executive Officer at
SciCann Therapeutics, Inc.
Profile
Dr. Zohar Koren is a Chief Executive Officer at OncoDecipher Ltd., a Chief Technology Officer at Xinteza API Ltd. and a Chief Executive Officer at SciCann Therapeutics, Inc. Dr. Koren was previously employed as a Chief Executive Officer & Director by Cannabics Pharmaceuticals, Inc. and a Founder by Cannabics, Inc. He also served on the board at Alterola Biotech, Inc. (California).
He received his undergraduate degree from The Hebrew University of Jerusalem, a graduate degree from the University of Haifa and a doctorate degree from the University of Haifa.
Zohar Koren active positions
| Companies | Position | Start |
|---|---|---|
SciCann Therapeutics, Inc.
 SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Chief Executive Officer | - |
Xinteza API Ltd.
 Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Founder | 2019-03-16 |
Oncodecipher
 Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Chief Executive Officer | 2024-01-31 |
Former positions of Zohar Koren
| Companies | Position | End |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Founder | 2015-01-22 |
| ALTEROLA BIOTECH, INC. | Director/Board Member | - |
Cannabics, Inc.
 Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Founder | - |
Training of Zohar Koren
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
CNBX Pharmaceuticals, Inc.
 CNBX Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer | Health Technology |
Alterola Biotech, Inc. (California)
 Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Manufactures medicament containing chewing gums | Process Industries |
Cannabics, Inc.
Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Finance |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Haifa
 University of Haifa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xinteza API Ltd.
Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
SciCann Therapeutics, Inc.
SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Oncodecipher
Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Technology Services |
- Stock Market
- Insiders
- Zohar Koren
